Abstract: The present invention relates to a topical spray composition comprising a biologically active vitamin D derivative or analog and a corticosteroid, and its use in the treatment of dermal diseases and conditions.

Abstract: A method of treating the hair including providing a concentrated hair care composition in a dispenser. The concentrated hair care composition includes one or more silicones, perfume, an emulsifier system, and from about 2% to about 10% high melting point fatty compounds. The method also includes dispensing the concentrated hair care composition from the dispenser, applying the concentrated hair care composition the hair; and rinsing the concentrated hair care composition from the hair.

Abstract: The present invention relates to an antiperspirant cosmetic agent including at least one specific protein from legumes of the genus Pisum and/or Phaseolus and/or Vigna and/or Macrotyloma or from cruciferous plants of the genus Brassica and including no aluminum and/or zirconium halides and/or hydroxyhalides. The present invention further relates to the use of a specific protein and to a non-therapeutic method for reducing body perspiration. Adding or using said at least one specific protein ensures that the sweat gland(s) are effectively influenced, thus resulting in a significant reduction in axillary sweat even in the absence of antiperspirant aluminum salts.

Abstract: An anhydrous antiperspirant aerosol composition comprising a particulate antiperspirant active system, suspending agent, carrier oil, and liquefied propellant gas, characterized in that the particulate antiperspirant active system comprises an aluminum sesquichlorohydrate of formula Al2(OH)4.4Cl1.6 to Al2(OH)4.9Cl1.1 activated with a water soluble calcium salt.

Abstract: The present invention provides a method of making up human keratinous material, the method comprising: taking at least two measurements of an optical characteristic of said keratinous material at different locations; and applying a composition to the keratinous material, the composition modifying a characteristic of the appearance of said keratinous material so as to give it an optical characteristic intermediate between the measured optical characteristics.

Abstract: Disclosed is cosmetic or dermatological preparation which comprises one or more antiperspirant substances and one or more cationic surfactants.

Abstract: Described herein are multifunctional polymers comprising a first repeating unit having at least one pseudo-cationic moiety, a second repeating unit having at least a hydrophobic moiety, and a third repeating unit, where the weight-average molecular weight is less than about 10,000 Da. In one embodiment the polymers exhibit antimicrobial activity. Also provided are compositions formulated with the multifunctional polymers, and a method of providing antimicrobial activity.

Abstract: A process for enhancing polyphenolics content of beverages brewed from polyphenolic containing, processed beverage substrate by pre-soaking substrate (coffee beans, for example) before roasting and then quenching the substrate after processing with the liquid in which the substrate was first “pre-soaked.” Beverages produced from the treated substrate exhibit substantially increased polyphenolics content, when compared to conventionally processed beverage substrate of the same nature and processing.

Abstract: An aerosol antiperspirant composition is provided. The aerosol antiperspirant composition includes a propellant and an antiperspirant composition. The antiperspirant composition includes one or more liquid materials, wherein the one or more liquid materials comprise one or more non-volatile silicone fluids having a concentration from 40% to about 70% by weight of the antiperspirant composition; antiperspirant active particulates having a concentration from about 16% to about 32% by weight of the antiperspirant composition; one or more non-antiperspirant active particulates that are substantially inert, wherein the one or more non-antiperspirant active particulates that are substantially inert have a concentration from 10% to 30% by weight of the antiperspirant composition; and wherein the antiperspirant composition has a total particulate concentration from 30% to about 60% by weight of the antiperspirant composition.

Abstract: An aerosol antiperspirant composition is provided. The aerosol antiperspirant composition includes a propellant having a concentration from 30% to 65% by weight and an antiperspirant composition. The antiperspirant composition includes one or more liquid materials, wherein the one or more liquid materials comprise one or more non-volatile silicone fluids having a concentration from 40% to about 70% by weight; antiperspirant active particulates; one or more non-antiperspirant active particulates that are substantially inert; and wherein the antiperspirant composition has a total particulate concentration from 30% to about 60% by weight and the antiperspirant composition has a viscosity greater than 1,000 centipoise.

Abstract: An aerosol antiperspirant composition is provided. The aerosol antiperspirant composition includes a propellant having a concentration from 70% to 90% by weight of the aerosol antiperspirant composition and an antiperspirant composition. The antiperspirant composition includes one or more liquid materials, wherein the one or more liquid materials comprise one or more non-volatile silicone fluids having a concentration from 40% to about 70% by weight of the antiperspirant composition, an antiperspirant active particulate, one or more non-antiperspirant active particulates that are substantially inert, wherein the one or more non-antiperspirant active particulates have a concentration from 10% to 30% by weight of the antiperspirant composition. The antiperspirant composition has a total particulate concentration from 30% to about 60% by weight of the antiperspirant composition.

Abstract: Formulations having, as active agents, at least one quaternized polymeric microgel and at least one nonionic surfactant, methods of making, and methods of using are described.

Abstract: Cosmetic agents and methods for temporarily shaping keratin-containing fibers using the cosmetic agents are provided herein. In one embodiment, a cosmetic agent for temporarily shaping keratinic fibers includes a cosmetic preparation. The cosmetic preparation contains at least one copolymer a1) composed of at least the following monomer units: (meth)acrylic acid, (meth)acrylic acid alkyl ester, and (meth)acrylic acid hydroxyalkyl ester. The cosmetic preparation further contains at least one copolymer a2) composed of at least the following monomer units: N-tert-octylacrylamide, acrylic acid, and ethyl acrylate. The amount by weight of copolymers a1) and a2) in the total weight of the cosmetic preparation amounts to about 1.0 to about 10 by weight.

Abstract: Cleaning compositions, which are typically self-adhering in gel form upon application to a hard surface, and which are desirably capable of being applied in aerosol form, are provided. The aqueous-based cleaning compositions include an adhesion promoter, which typically includes one or more organic molecules, each containing at least one hydrophilic group; and an anionic, nonionic, cationic, amphoteric and/or zwitterionic surfactant; and (c) a propellant. In many embodiments, the aqueous-based composition and propellant are contained within a single compartment of a dispensing device.

Abstract: A method of treating the hair including providing a concentrated hair care composition in an aerosol foam dispenser. The concentrated hair care composition includes one or more silicones, perfume, and less than 10% high melting point fatty compounds. The method also includes dispensing the concentrated hair care composition from the aerosol foam dispenser as a dosage of foam; applying the foam to the hair; and rinsing the foam from the hair. The foam has a density of from about 0.025 g/cm3 to about 0.40 g/cm3 when dispensed from the aerosol foam dispenser.

Abstract: Cleansing composition comprising the following components (A), (B), and (C): (A) 0.02% by mass or larger and 10% by mass or smaller of a polymer comprising 85 to 100% by mass as constitutional units of a1: a constitutional unit represented by the formula (1): wherein R1 and R2 each represents an alkyl group having 1 to 4 carbon atoms and optionally having a hydroxy group, or a hydrogen atom, and R3 represents a hydrogen atom or a methyl group, and a2: a constitutional unit represented by the formula (2): wherein R4 represents a linear or branched alkyl group having 1 to 22 carbon atoms, and R5 represents a hydrogen atom or a methyl group; (B) 0.5% by mass or larger and 40% by mass or smaller of an anionic surfactant; and (C) water.

Abstract: The present invention relates to foamable oil-in-water emulsions containing: A) one or more emulsifiers, at least one of which is a non-ionic emulsifier, B) one or more cotensides, C) one or more oils, D) optionally, one or more polar solubilizers, E) optionally, auxiliary and additive substances, F) one or more surfactants, G) water, H) optionally, water-soluble substances, provided that the water content of the emulsion is ?70% by weight and the concentration of surfactant(s) F) is from 0.01 to less than 10% by weight, each based on the entire emulsion. The invention further relates to a method for producing the oil-water emulsions according to the invention, to foams obtained from these oil-water emulsions, to a method for producing the foams, and to the application of the oil-water emulsions according to the invention and to the foams produced therefrom.

Abstract: The invention relates to N-alkyl-N-acylglucamines of formula (I), which exhibit in hair-washing agents comprising an aqueous surfactant system with at least one anionic surfactant, a hair-conditioning effect, wherein, in formula (I), Ra is a linear or branched, saturated or unsaturated C5-C21 alkyl radical and Rb represents a C1-C4 alkyl radical, and wherein the N-alkyl-N-acylglucamines (I) contain at least 8 wt. %, based on the total amount of N-alkyl-N-acylglucamines (I), of compounds with a saturated C16-, C18- or a mono- or polyunsaturated C18 fatty acid radical Ra—CO—.

Abstract: A composite material for the production of a medical device having an antiseptic action includes a matrix of alginate in which the complex of iodopovidone is dispersed. The composite material is used particularly for the production of films, micro-capsules, and suture threads with iodine controlled release.

Abstract: The present invention relates generally to surfactant and detergent compositions and, more specifically, to surfactant and detergent compositions containing a propoxylated glycerine.

Abstract: A method for providing a customized skin care product to a customer and skin care kit are disclosed. The method includes obtaining information from a customer regarding current skin conditions, analyzing the information to identify a plurality of target skin conditions in response to the current skin conditions, correlating booster compositions to the target skin conditions, the booster compositions including active ingredients corresponding to the target skin conditions, and assembling a skin care kit, the skin care kit including a base oil composition and a plurality of booster compositions having actives corresponding to the target skin conditions. The base oil composition and plurality of boosters are mixable to obtain a treatment composition at any point in time prior to application to skin.

Abstract: The present disclosure refers to topical pharmaceutical bases that possess scar healing properties. Further, these topical pharmaceutical bases are proposed for treating skin conditions, such as, for example keloids, hypertrophic scars, wounds, and burns, among others. The topical pharmaceutical bases include Amazonian oils and resins, such as pracaxi oil and breu-branco resin. The synergistic effect of pracaxi oil combined with breu-branco resin results in a highly effective scar and wound treatment. Suitable active pharmaceutical ingredients (APIs) can be incorporated to the topical pharmaceutical bases to formulate topical pharmaceutical compositions, which improve healing effects. The synergistic effect provided by the combination of pracaxi oil and breu-branco resin enables lower dosage requirements of the associated APIs when topical pharmaceutical compositions are employed for treating skin conditions.

Abstract: The invention provides a method of producing a highly stable pharmaceutical aerosol suspension formulation suitable for use in a metered dose inhaler, the formulation comprising formoterol fumarate di-hydrate in suspension, a steroid in suspension, a propellant and ethanol, the method comprising the steps of drying the formoterol fumarate di-hydrate to a water content of 4.8 to 4.28%.

Abstract: Disclosed is a shaving preparation imparting durable lubricity. The shaving preparation has one or more silicone polyethers and one or more water-soluble polymers that associate with the one or more silicone polyethers in aqueous solution. The lubricity of the shaving preparation can be reactivated by wetting the skin after shaving without applying an additional amount of the shaving preparation. Also disclosed is a method for using the shaving preparation.

Abstract: The pulvurent effervescent topical treatment compositions comprise: at least 50% wt. of a gas generating system which comprises both a gas generating constituent as well as a complementary reactive acid constituent, which constituents, when combined in the presence of water or another largely aqueous medium generates a gas, preferably carbon dioxide; 5-50% wt. of an anionic soap and/or anionic surfactant constituent; 0.0001-1.5% wt. of an antimicrobial constituent; 0.0001-3 an exogenous product of Sclerotium rolfsii, and, optionally one or more filler constituents, preferably based on materials which are inert with respect to the gas generating constituent and which also are inert with respect to the antimicrobial constituent; further optionally, one or more further constituents which may be included to provide a desired aesthetic benefit, e.g., a fragrance, colorant and/or a desired technical benefit, e.g.

Abstract: Novel anticoagulant reversal compounds are disclosed, as well as methods of making the compounds, pharmaceutical compositions including the compounds, methods of using the compounds to reverse the anticoagulant effects of coagulation inhibitors, and diagnostic assays comprising the compounds.

Abstract: The present disclosure refers to topical pharmaceutical bases that possess anti-inflammatory properties. Further, these topical pharmaceutical bases are proposed for treating inflammatory disorders, such as swollen tissues within joints and muscles, and the like. The topical pharmaceutical bases include Amazonian oils and resins, such as pracaxi oil and breu-branco resin. The synergistic effect of pracaxi oil combined with breu-branco resin results in a highly effective anti-inflammatory treatment. Suitable active pharmaceutical ingredients (APIs) can be incorporated to the topical pharmaceutical bases to formulate topical pharmaceutical compositions, which improve anti-inflammatory effects. The synergistic effect provided by the combination of pracaxi oil and breu-branco resin enables lower dosage requirements of the associated APIs when topical pharmaceutical compositions are employed for treating inflammatory disorders.

Abstract: A composition for lubricant formulations is disclosed. The composition may include hypochlorite, dimethicone, and an emulsifier for improvement of lubricity. Methods of making and using the lubricant formulations are also disclosed.

Abstract: A protective coating solution, liquid, gel, or film and a method of using such a material to provide a sterile covering for fingers, hands, arms or other selected skin surface for use as a glove substitute.

Abstract: This application is directed to hair and skin conditioning compositions which contain specific polyoxyalkylene substituted alkylene diamines. The polyoxyalkylene substituted alkylene diamines function as conditioning agents on hair and skin via cloud point deposition. The polyoxyalkylene substituted alkylene diamines in addition to functioning as conditioning agents on skin and hair by themselves also function to enhance deposition of lipophilic benefit agents such as for example fatty alcohols, esters of fatty acids, hydrophobic vitamin or vitamin complexes, natural or synthetic triglycerides including glyceryl esters and derivative, pearlescent waxes, hydrocarbon oils, siloxanes of silicones, perfume oils, super-fatting agents, water insoluble or slightly soluble organic sunscreens, micronized sunscreens, plant extracts, essential oils and hydrophobically modified pigments.

Abstract: Formulations having, as active agents, at least one quaternized polymeric microgel and at least one surfactant, methods of making, and methods of using are described.

Abstract: A kit for the production of an antimicrobial foam includes: a) a liquid composition which includes a1)one or more bispyridinium alkane and a2)one or more surfactants selected from non-ionic surfactants, amphoteric surfactants and cation-active surfactants, wherein the composition is formulated so that a foam can be produced therefrom, and b) a device for producing the foam from the composition. By using the bispyridinium alkanes the foam stability of liquid and surfactant-containing compositions is increased.

Abstract: The present invention provides compositions, kits and methods for treating scalp hair. The compositions include fluorinated (but not perfluorinated), non-polymeric compounds in a suitable excipient to provide beneficial effects on hair.

Abstract: Disclosed is the use of a UV filter combination, comprising (a) a first UV filter selected from benzylidene malonates of formula (1), wherein R1 methyl; ethyl; propyl; or n-butyl; if R1 is methyl, then R is tert.

Abstract: A liquid cosmetic which minimizes stickiness or stiffness caused by the incorporation of a large amount of a moisturizing agent is provided. This liquid cosmetic contains 10 to 40% by mass of a moisturizing agent (a), 0.01 to 3% by mass of an oil (b), 0.01 to 5% by mass of a hydrophilic surfactant (c), and 0.001 to 0.3% by mass polyacrylic acid or a metal salt thereof (d), and wherein an average emulsified particle size is 500 nm or smaller. Preferably, the amount of polyalkylene glycol contained in the moisturizing agent (a) is adjusted to 0.1 to 3 mass % relative to the whole cosmetic.

Abstract: Compositions (3) and methods of using such compositions (3) to condition, clean, or disinfect the flow path of a conduit (8) of a microfluidic devices (16), such as flow cytometers or liquid chromatographs.

Abstract: A composition for reducing sebum production in the skin of a user, the composition comprising: a liquid carrier; and Pyridoxine Cyclic Phosphate; wherein the Pyridoxine Cyclic Phosphate is present in the composition in a concentration sufficient to reduce sebum production in the skin of a user when the composition is applied to the skin of a user.

Abstract: The invention relates to shampoo preparations comprising water, an acrylic emulsion polymer and at least one surfactant. The preparations provide improved styling performance and improved hair feel.

Abstract: Long-lasting fragrance delivery systems and uses of the systems to provide fragrance-emitting articles with a long-lasting fragrance are disclosed herein. The long-lasting fragrance delivery systems include an emulsion of silicone-based polyurethane, fragrance, and a carrier.

Abstract: The present invention provides cosmetic formulations for improving the appearance of the skin, including the facial area. The compositions of the invention provide multiple enhanced technologies that work synergistically to enhance hydration and appearance of the skin. Anti-aging peptides and tissue respiratory factor work together in an HA rich environment to enhance collagen and elastin while beneficial antioxidants protect HA in the skin from damaging exposure.

Abstract: The present invention provides methods of administering an active agent to a specifically identified area of mucous membrane of a human being, as well as a body dissolving film formed therefore.

Abstract: The present invention, as described above and as further defined by the claims, provides methods of administering an active agent via adhesion of a film to a mucous membrane in the oral cavity of a mammal, as well as and ODF formed therefore. An active agent may be ingested as the ODF dissolves resulting in systemic treatment of the mammal. In additional embodiments, an ODF may provide topical administration of an active agent.

Abstract: The present invention relates to stable substantially non-aqueous, non-alcoholic, non-silicone, foamable carrier compositions comprising petrolatum or mixtures thereof, at least one foam agent, at least one propellant, and with and without the addition of an active agent. The formulations may contain a solvent substantially miscible therein. The present invention further provides a method of treating, alleviating or preventing a disorder of mammalian subject in need thereof, comprising administering the above-mentioned compositions to an afflicted target site of said mammalian subject.

Abstract: A composition and method of eliminating pests combines water and a solid form of sodium lauryl sulfate to form a pesticide composition effective to cause mortality in pests. The composition is applied to the indoor structure in an area which the pests inhabit. The sodium lauryl sulfate can be in needle form, pellet form or powder form and constitutes between about 1% and about 10% by weight of the pesticide composition. The composition may be applied to an area inhabited by cockroaches, including, but not limited to, in crevices, cracks, corners, wall and floor junctures or other enclosed or partially enclosed areas of a structure.

Abstract: Provided are compositions, e.g., oral and personal care products, comprising (i) a zinc (amino acid or trialkyl glycine) halide complex, and (ii) cysteine in free or in orally or cosmetically acceptable salt form, together with methods of making and using the same.

Abstract: Functionalized alternan polysaccharide, comprising nitrogen groups or permanently positively charged nitrogen groups that can be protonated as functional groups and can be described by the following formula, for instance: (I) wherein R1 is a hydrocarbon group with 1 to about 100 carbon atoms, that may comprise one or more heteroatoms, R2 and R3 are each a hydrogen or a hydrocarbon group with 1 to about 20 carbon atoms that can comprise one or more heteroatoms, wherein R2 and R3 can be the same or different, or R2 and R3 form a 4-8 membered heterocyclic ring together with the nitrogen to which they are bound; Wherein said ring can be condensed with one or more additional isocyclic or heterocyclic rings, wherein the nitrogen can be bound to one of the R2 or R3 groups by way of a double bond and then bears a positive charge, wherein the nitrogen in Formula (I) is optionally protonated, and wherein the residues R1, R2 and R3 can be selected independently from each other in multiple —R1NR2R3 groups.

Abstract: Disclosed is a method of treating skin, the method comprising topically applying to skin a composition comprising at least one aqueous and/or alcoholic plant extract.

Abstract: An aerosol antiperspirant composition is provided. The aerosol antiperspirant composition includes a propellant having a concentration from 70% to 90% by weight of the aerosol antiperspirant composition and an antiperspirant composition. The antiperspirant composition includes one or more liquid materials, wherein the one or more liquid materials comprise one or more non-volatile silicone fluids having a concentration from 40% to about 70% by weight of the antiperspirant composition, an antiperspirant active particulate, one or more non-antiperspirant active particulates that are substantially inert, and a silicone sum having a concentration from 0.1% to 1.5% by weight of the antiperspirant composition.

Abstract: The present application relates to organosilicones and compositions such as consumer products comprising such organosilicones, as well as processes for making and using such organosilicones and such compositions. Such compositions comprising such organosilicones are easier to formulate, and provide more economical and superior care benefits when compared to current silicone containing compositions.

Abstract: A hygroscopic pharmaceutical composition includes at least one hygroscopic substance at a concentration sufficient to provide an Aw value of less than 0.9 or about 0.9 to about 0.7 and an antiinfective agent. A foamble pharmaceutical carrier includes about 50% to about 98% of a polar solvent selected from the group consisting of a polyol and PEG; 0% to about 48% of a secondary polar solvent; about 0.2% to about 5% by weight of a surface-active agent; about 0.01% to about 5% by weight of at least one polymeric agent; and a liquefied or compressed gas propellant at a concentration of about 3% to about 25% by weight of the total composition.